Smock Kristi J, Perkins Sherrie L, Bahler David W
Department of Pathology, University of Utah, Salt Lake City, UT, USA.
Arch Pathol Lab Med. 2007 Jun;131(6):951-5. doi: 10.5858/2007-131-951-QOPCIB.
Accurate quantitation of bone marrow plasma cells is an important component in the diagnosis and posttreatment assessment of plasma cell dyscrasias. Although flow cytometry is sometimes used for this purpose and can rapidly evaluate many cells, the accuracy of flow-based plasma cell quantitation compared with morphologic assessment (currently the gold standard) is uncertain as direct comparison studies have not been previously reported.
To determine how percentages of plasma cells in diagnostic aspirate smears quantitated by morphologic assessment relate to percentages of plasma cells quantified by flow cytometry.
Thirty bone marrow cases with 10% or more plasma cells and leukemia/lymphoma flow cytometry immunophenotyping studies were identified from our hematopathology database. The Wright-stained aspirate smears, marrow biopsy sections, and flow cytometry histograms were reviewed.
Morphologically determined plasma cell percentages from the diagnostic aspirate smears were consistently higher than those determined by flow cytometry. Much of this difference appeared to be related to differences in sample quality. However, the cellular processing involved in performing flow cytometry also appeared to reduce plasma cell percentages in many cases.
This study helps define the limitations of flow cytometry for quantitating plasma cell loads in marrow aspirate specimens that may significantly affect the diagnosis or assessment of treatment response.
准确量化骨髓浆细胞是浆细胞异常增生性疾病诊断和治疗后评估的重要组成部分。尽管流式细胞术有时用于此目的且能快速评估许多细胞,但与形态学评估(目前的金标准)相比,基于流式细胞术的浆细胞定量的准确性尚不确定,因为此前尚未有直接比较研究报道。
确定通过形态学评估定量的诊断性穿刺涂片浆细胞百分比与通过流式细胞术定量的浆细胞百分比之间的关系。
从我们的血液病理学数据库中识别出30例骨髓浆细胞比例达到或超过10%的病例以及白血病/淋巴瘤流式细胞术免疫表型研究。对瑞氏染色的穿刺涂片、骨髓活检切片和流式细胞术直方图进行了复查。
诊断性穿刺涂片形态学确定的浆细胞百分比始终高于流式细胞术确定的百分比。这种差异很大程度上似乎与样本质量差异有关。然而,在许多情况下,进行流式细胞术所涉及的细胞处理似乎也会降低浆细胞百分比。
本研究有助于明确流式细胞术在定量骨髓穿刺标本中浆细胞负荷方面的局限性,这可能会显著影响诊断或治疗反应评估。